Profund Advisors’s Cymabay Therapeutics CBAY Stock Holding History

Profund Advisors’s Portfolio CBAY Stock Details CBAY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-26,263	Closed	-$620K	–	1205
2023 Q4	$620K	Buy	26,263 +7,302	+39%	+$130K	0.03%	451
2023 Q3	$283K	Sell	18,961 -790	-4%	-$10.5K	0.02%	692
2023 Q2	$216K	Buy	19,751 +6,548	+50%	+$61K	0.01%	931
2023 Q1	$115K	Buy	+13,203	New	+$106K	0.01%	1052
2019 Q1	–	Sell	-18,066	Closed	-$142K	–	1251
2018 Q4	$142K	Sell	18,066 -3,478	-16%	-$33.1K	0.01%	1067
2018 Q3	$239K	Buy	+21,544	New	+$268K	0.01%	1347

Other funds holding CBAY

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Profund Advisors's CBAY Position: Q1 2024 in Review

Profund Advisors sold out of Cymabay Therapeutics (CBAY) in Q1 2024, closing a stake of 26,263 shares — an estimated $620K sold.

Profund Advisors first reported a position in CBAY in Q3 2018 and held it in 6 quarters. The position peaked at $620K in Q4 2023. 1 fund tracked by Wall St. Rank holds CBAY as of Q1 2024.

Profund Advisors reported no remaining Cymabay Therapeutics position as of Q1 2024 after selling out during the quarter.
Profund Advisors sold 26,263 Cymabay Therapeutics shares in Q1 2024, an estimated $620K.
Profund Advisors first reported a position in Cymabay Therapeutics in Q3 2018 and held it in 6 quarters.
Profund Advisors's Cymabay Therapeutics position peaked at $620K in Q4 2023.
1 fund tracked by Wall St. Rank held Cymabay Therapeutics as of Q1 2024.

Based on Profund Advisors's 13F filing for Q1 2024, filed 8 May 2024.